Serzone

Depression

Treatment

1 FDA approval

20 Active Studies for Serzone

What is Serzone

Nefazodone

The Generic name of this drug

Treatment Summary

Nefazodone hydrochloride (brand name Serzone) was an antidepressant drug made by Bristol-Myers Squibb. In 2003, it was discontinued in some countries due to a very small risk of liver damage. In rare cases, it was linked to a need for a liver transplant or death. On May 20, 2004, Bristol-Myers Squibb stopped selling Serzone in the United States.

Serzone

is the brand name

image of different drug pills on a surface

Serzone Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Serzone

Nefazodone

1994

33

Approved as Treatment by the FDA

Nefazodone, otherwise known as Serzone, is approved by the FDA for 1 uses like Depression .

Depression

Effectiveness

How Serzone Affects Patients

Nefazodone is a medication used to treat major depression. It is similar to the antidepressant trazodone, but works differently, and has fewer risks of serious cardiovascular problems or insomnia than other antidepressants.

How Serzone works in the body

Nefazodone works on two different systems in the body. First, it increases the amount of serotonin available to interact with serotonin receptors. Second, it blocks the effects of norepinephrine, a chemical that helps to regulate the body's response to stress. Nefazodone also has less significant effects on other receptors, like benzodiazepine and cholinergic receptors.

When to interrupt dosage

The proposed measure of Serzone is contingent upon the diagnosed condition. The quantity of dosage additionally depends on the approach of delivery (e.g. Tablet or Tablet - Oral) documented in the table below.

Condition

Dosage

Administration

Depression

, 100.0 mg, 200.0 mg, 250.0 mg, 150.0 mg, 50.0 mg

, Oral, Tablet, Tablet - Oral

Warnings

Serzone Contraindications

Condition

Risk Level

Notes

Pulse Frequency

Do Not Combine

Pulse Frequency

Do Not Combine

Pulse Frequency

Do Not Combine

Pulse Frequency

Do Not Combine

Liver

Do Not Combine

Pulse Frequency

Do Not Combine

Pulse Frequency

Do Not Combine

There are 20 known major drug interactions with Serzone.

Common Serzone Drug Interactions

Drug Name

Risk Level

Description

(R)-warfarin

Major

The metabolism of (R)-warfarin can be decreased when combined with Nefazodone.

(S)-Warfarin

Major

The metabolism of (S)-Warfarin can be decreased when combined with Nefazodone.

1,2-Benzodiazepine

Major

The metabolism of 1,2-Benzodiazepine can be decreased when combined with Nefazodone.

3,5-diiodothyropropionic acid

Major

The metabolism of 3,5-diiodothyropropionic acid can be decreased when combined with Nefazodone.

5-androstenedione

Major

The metabolism of 5-androstenedione can be decreased when combined with Nefazodone.

Serzone Toxicity & Overdose Risk

In some cases, taking nefazodone can result in a dangerous form of liver failure.

image of a doctor in a lab doing drug, clinical research

Serzone Novel Uses: Which Conditions Have a Clinical Trial Featuring Serzone?

Currently, 601 active clinical trials are underway to explore the possible utilization of Serzone in addressing Depression.

Condition

Clinical Trials

Trial Phases

Depression

300 Actively Recruiting

Not Applicable, Phase 1, Phase 2, Early Phase 1, Phase 4, Phase 3

Serzone Reviews: What are patients saying about Serzone?

5

Patient Review

1/23/2013

Serzone for Major Depressive Disorder

Since returning from Vietnam in 1971 and diagnosed at that time with PTSD I was subjected to 11 years of trial and error with all drugs. Nefazadone has been the best for me and highly reccomended. Man what a difference I see when NOT taking it for a couple of days.

5

Patient Review

9/28/2013

Serzone for Depression

I was diagnosed with PTSD, panic disorder, insomnia and depression six months ago. I started taking ATIVAN but didn't like the effects, so my doctor put me on colozapam. It works OK but I still have angry outbursts, so now I am trying nefazadone. So far it seems to be working.

5

Patient Review

1/1/2015

Serzone for Depression

Nefazadone/sera zone has been a life-changing medication for me. After trying 7 different antidepressants that didn't work, I was finally prescribed this drug about 17 years ago. It's helped me immensely and I'm now looking to start my doctoral degree. I would love to do research related to this drug and its efficacy in treating depression and ADHD.

5

Patient Review

1/15/2022

Serzone for Depression

Nefazodone's recent availability has been a godsend. It has really helped with my depression and anxiety, to the point where I've been taking it for over 20 years without any side effects. Honestly, none of the other medications I tried did anything remotely as effective as this one when it comes to reducing my anxiety.

5

Patient Review

5/12/2012

Serzone for Depression

I've been taking this medication for over 20 years, but recently I haven't been able to get it because of backorders from the manufacturer. Do you know what's causing the issue and if there's a comparable substitute?

5

Patient Review

3/12/2022

Serzone for Panic Disorder

I'm so glad that Nefazodone is available again. This medication has been a life-changer for me, helping with my anxiety in a way that nothing else has ever done before. If you're struggling with this issue, I recommend checking out the Facebook Support group "Nefazodone Shortage Survivors and Support."

5

Patient Review

4/28/2010

Serzone for Depression

5

Patient Review

10/18/2010

Serzone for Depression

I've been taking this for 10 years and it's really helped me. I tried other antidepressants before this one, but the side effects were too much to handle. With this medication, my liver tests have come back fine and there's no nausea if I take it with food. It's allowed me to live a normal life again and I'm very grateful for that.

5

Patient Review

9/13/2013

Serzone for Depression

I was unable to get assistance with getting the medications. Can't afford it. No income, unemployed for over 2 years.

5

Patient Review

4/28/2010

Serzone for Depression

5

Patient Review

10/18/2010

Serzone for Depression

I've been taking this medication for a decade and it has really improved my quality of life. I've tried other antidepressants that come with nasty side effects, but this one is much more tolerable. So long as I take it with food, I don't experience any nausea either.

5

Patient Review

1/23/2013

Serzone for Major Depressive Disorder

Since I was diagnosed with PTSD after returning from Vietnam in 1971, I've tried a lot of different medications. Nefazadone has been the best for me by far, and I highly recommend it to others. It's made such a difference in my life that it's hard to go even a couple days without it.

5

Patient Review

5/12/2012

Serzone for Depression

I've been taking this medication for over 20 years, but recently I haven't been able to get it because of manufacturer backorders. Do you know what the problem is and if there's a comparable substitute?

5

Patient Review

9/28/2013

Serzone for Depression

I've been dealing with some serious mental health issues for the past six months, including PTSD, severe panic disorder, insomnia and depression. I was originally prescribed Ativan, but didn't like the way it made me feel. So then my doctor put me on colozapam, which helped a little bit but I still had angry outbursts. Today is my first day taking nefazadone and so far it seems to be working well.

5

Patient Review

1/1/2015

Serzone for Depression

After trying 7 antidepressants that didn't work 20 years ago, I'm hyperactive also, I finally was prescribed nefazadone/sera zone about 17 years ago. It's been a blessing. I finished my master's degree 5 years ago and looking to start my doctoral.

5

Patient Review

9/13/2013

Serzone for Depression

I was unable to get assistance with getting the medications. I couldn't afford it and have been unemployed for over 2 years.

5

Patient Review

1/15/2022

Serzone for Depression

Nefazodone has been re-stocked and I am so grateful. This medication has done worlds of good for my depression and anxiety-- better than any other antidepressant I've tried in the 20 years I've been taking it.

5

Patient Review

3/12/2022

Serzone for Panic Disorder

I'm so glad that Nefazodone is available again. I've been taking it for over 20 years and it's the only thing that helps with my anxiety. There's a great Facebook support group called "Nefazodone Shortage Survivors and Support" where you can find more information about this medication.

4.7

Patient Review

5/31/2012

Serzone for Depression

I've been taking this medication for 10 years and it's worked great for me, but now my pharmacy is having trouble filling my prescription. I'm not sure what's going on, but I hope they can continue to provide this product.

4.7

Patient Review

9/29/2013

Serzone for Depression

I've been on this medication for a prolonged period of time and it has drastically improved my quality of life. That being said, sometimes it can be difficult to find my 200 mg dose in stores.

4.7

Patient Review

8/10/2019

Serzone for Major Depressive Disorder

I miss this medication dearly; it was the only one that effectively treated my depression and anxiety. The side effects, while not ideal, were manageable for me. I think it's really important that this drug be available again in Australia.

4.7

Patient Review

8/10/2019

Serzone for Major Depressive Disorder

I took this medication for several years before it was withdrawn from the market in Australia. It was the only medication that treated my depression & anxiety. Side effects for me were heavy sedation (especially in mornings), restless legs, nausea, weight loss. But overall, I think the side effects were worth it. My liver function was monitored via blood tests and it was fine. Bring this back to the market in Australia; it is vital! There is no equivalent!

4.7

Patient Review

5/31/2012

Serzone for Depression

I've been taking this medication for 10 years and have had great results. However, my pharmacist is now having difficulty filling my prescription. I would like to know why this is happening and if there are any alternatives available.

4.7

Patient Review

9/29/2013

Serzone for Depression

I've been on this medication for a long time and it has really changed my life for the better. That said, I have run into issues in the past where my pharmacist wasn't able to fill my script for the 200mg dose that I need.

3

Patient Review

6/6/2022

Serzone for Depression

I just started this medication and I'm already feeling drowsy. I only took 100mg, is this normal? Will the effects wear off over time?

3

Patient Review

6/6/2022

Serzone for Depression

I've just started taking this medication, and I'm already feeling very drowsy. I only took 100mg, is this normal? Will the side effects go away?

2.3

Patient Review

11/4/2012

Serzone for Major Depressive Disorder

My blood pressure rose to an unhealthy level after only a couple weeks, and I experienced other issues like shaking and memory problems. I had to go the hospital, where they said everything was fine and charged me $6,000.

2.3

Patient Review

11/4/2012

Serzone for Major Depressive Disorder

My blood pressure spiked alarmingly after only a couple weeks of taking this medication. I also started shaking and forgetting things. I had to go to the hospital, where they said there was no issue. Without insurance, this treatment cost me $6,000 out of pocket.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about serzone

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Why is nefazodone no longer used?

"The antidepressant nefazodone hydrochloride (Serzone) is being discontinued by the manufacturer due to concerns of hepatotoxicity. The last day of sale will be Nov. 27, 2003."

Answered by AI

What kind of drug is Serzone?

"SERZONE works by blocking the reuptake of serotonin, a neurotransmitter in the brain, by neurons. This action increases the level of serotonin in the brain and helps relieve depression.

SERZONE is an antidepressant that is taken orally. It works by blocking the reuptake of serotonin, a neurotransmitter, by neurons. This action increases the level of serotonin in the brain and helps relieve depression."

Answered by AI

Is Serzone still prescribed?

"The brand medication of Nefazodone, Serzone, was discontinued in 2003 in the United States due to the rare occurrence of severe liver damage."

Answered by AI

Is Serzone an SSRI or an SNRI?

"Nefazodone is not in the same class of drugs as the serotonin reuptake inhibitors (SSRIs), the tricyclic antidepressants (TCAs), or the monoamine oxidase (MAO) inhibitors. It is similar to another antidepressant, trazodone (Desyrel), in terms of how it works. The FDA approved nefazodone in December 1994."

Answered by AI

Clinical Trials for Serzone

Image of Stanford University School of Medicine in Stanford, United States.

BEAR Program for Suicidal Thoughts

18 - 75
Female
Stanford, CA

The current study aims to test the feasibility of a new form of group therapy for women who have a history of interpersonal trauma and current suicidal ideation. The Building Empowerment and Resilience (BEAR) Therapeutic group has been adapted for women who have experienced trauma and have current suicidal ideation. It incorporates psychological skills, psychoeducation about trauma and gender-based violence, and physical self-defense training, all within a therapeutic process. It will be implemented with women who have experienced interpersonal trauma (physical, sexual, or emotional abuse/neglect) and experience various mental health difficulties, including suicidal ideation. We aim to assess the feasibility to recruit and implement the BEAR group. Our ultimate aim is to assess whether the program can effect self-efficacy and suicidal ideation.

Waitlist Available
Has No Placebo

Stanford University School of Medicine

Jennifer Keller, PhD

Image of Western Psychiatric Hospital/University of Pittsburgh in Pittsburgh, United States.

Sleep and Circadian Interventions for Suicide

18 - 25
All Sexes
Pittsburgh, PA

The purpose of this study is to examine the extent to which delivering sleep and circadian focused interventions in addition to evidenced based psychiatric care for depression and suicide risk may contribute to decreasing suicide risk among high risk young adults. Investigators will evaluate three interventions targeting sleep in acutely suicidal college students enrolled in intensive outpatient treatment. Participants will be randomly assigned to one of three intervention groups: 1. Triple Chronotherapy (TCT)+ Transdiagnostic Sleep and Circadian Intervention (TSC) 2. Transdiagnostic Sleep and Circadian Intervention (TSC) 3. Sleep Feedback (SF) Participants will be followed for 6 months with primary outcome domains of suicidal thoughts and behaviors and depression evaluated by blinded clinicians at short (Days 1-4 of intervention), medium (2 months) and long (6 month) term intervals.

Waitlist Available
Has No Placebo

Western Psychiatric Hospital/University of Pittsburgh

Tina Goldstein, PhD

Image of University of South Florida in Tampa, United States.

WeACT Program for Caregivers of People With Dementia

18+
All Sexes
Tampa, FL

The goal of this clinical trial is to learn whether WeACT, a self-paced, web-based program, is feasible and helpful for adult family caregivers of a relative living with dementia. WeACT is based on acceptance and commitment therapy (ACT), which teaches skills to handle difficult thoughts and feelings and take steps toward what matters most. The main questions this study aims to answer are: * Can caregivers complete WeACT as planned? * Do caregivers show improvements in mental health and coping after using WeACT? * What are caregivers' experiences with the program, and what suggestions do they have to improve it? Participants will: * Complete six self-paced weekly online modules and use the daily practice section during the program. * Complete online questionnaires before starting and after completing the program. * Take part in one online interview about their experience.

Waitlist Available
Has No Placebo

University of South Florida

Areum Han

Image of Fred Hutch/University of Washington Cancer Consortium in Seattle, United States.

Psilocybin Therapy for Anxiety and Depression in Cancer

18 - 85
All Sexes
Seattle, WA

This phase II trial tests the safety, side effects and how well group retreat psilocybin therapy works for the treatment of anxiety and depression in patients with solid tumors that have spread from where they first started (primary site) to other places in the body (metastatic) or with hematologic cancers for which no treatment is currently available (incurable). For patients with metastatic, incurable cancer, unrelieved anxiety and existential distress can cause profound suffering. Psilocybin therapy can relieve anxiety and existential distress by disrupting patterns of thinking that contribute to anxiety and depression. Psilocybin is a substance being studied in the treatment of anxiety or depression in patients with cancer. In this study, a pharmaceutical grade of psilocybin will be used that has been approved by the FDA for research, provided by Filament Health. Psilocybin acts on the brain by resetting the brain's activity and increasing connections between brain regions, particularly those involved in mood regulation and self-perception. In this study psilocybin is combined with structured discussions and reflections that enable patients to have new insights about their situation. In a prior study, group retreat psilocybin therapy was proven to be safe and this study tests a refined dosing regimen for symptoms of anxiety and depression in patients with metastatic solid tumors or incurable hematologic malignancies.

Phase 2
Waitlist Available

Fred Hutch/University of Washington Cancer Consortium

Anthony Back, MD

Have you considered Serzone clinical trials?

We made a collection of clinical trials featuring Serzone, we think they might fit your search criteria.
Go to Trials
Image of Seaway Valley Community Health Centre (Cardiac Rehab Program) in Cornwall, Canada.

FRAME for Heart Failure

18+
All Sexes
Cornwall, Canada

Heart failure is a high-risk, chronic condition that impacts patients' mental health. Approximately 50% of heart failure patients experience comorbid mental health conditions, such as stress, depression and anxiety, which affect their day-to-day lives. Despite this interconnection, the integration of mental health awareness and support into cardiac care remains limited. To address this gap, the FRAME (Foundation, Recognition, Awareness, Management, Engagement) intervention was co-designed by researchers, healthcare providers, health system decisionmakers, and patient partners. This pilot study evaluates the feasibility of implementing the FRAME intervention in pilot clinical sites within two health regions in Ontario, Canada, including team-based family medicine clinics, cardiac rehabilitation/specialist clinics, and emergency departments. Utilizing a pretest-posttest hybrid 1 model intervention design, this study evaluates process indicators and patient-focused outcomes through surveys and semi-structured qualitative interviews. Findings from this study will inform a future large scale cohort study and scalable integration of the FRAME tool into existing cardiac care pathways to enhance mental health awareness and support among heart failure patients.

Recruiting
Has No Placebo

Seaway Valley Community Health Centre (Cardiac Rehab Program) (+8 Sites)

Image of Lincoln Middle School in Cottage Grove, United States.

Behavioral Interventions for Depression in Students

Any Age
All Sexes
Cottage Grove, OR

The goal of this clinical trial is to learn if two behavioral interventions work to reduce office disciplinary referrals, improve attendance, and reduce depression and anxiety in 7th grade students. This project combines two evidence-based programs-the Inclusive Skill-building Learning Approach (ISLA) for school-wide discipline reform and the Family Check-Up Online (FCU-O) for family-centered support-in an adaptive design to examine the unique and additive effects of these interventions on these child behavior outcomes. The main questions it will answer are: 1. What is the relative efficacy of ISLA vs. School-as-Usual? 2. What is the optimal sequencing of these interventions? 3. Which overall sequence of intervention strategies was most effective? Researchers will compare 6 combinations of these interventions to see which combination and sequencing provides the best student outcomes. School personnel participating in the project will be trained to implement the two interventions at their school. They will answer surveys in the fall, winter, and spring of their year of participation. Parent and Youth participants will complete surveys at baseline and then again 6 months and 12 months later.

Waitlist Available
Has No Placebo

Lincoln Middle School (+12 Sites)

Beth Stormshak, PhD

Image of Cedars-Sinai Medical Center in Los Angeles, United States.

Living Well Program for Anxiety in Breast Cancer

18+
Female
Los Angeles, CA

The goal of this study is to evaluate the efficacy and cost-effectiveness of the Living Well Program, a digital therapeutic application with telecoaching support, in breast cancer patients with moderate-to-severe anxiety. The main question the study aims to answer is: does digital cognitive-behavioral therapy-based interventions decrease the overall healthcare costs of patients with stage II to IV breast cancer? The study has one group of participants who will use the Living Well app and telecoaching support. This group will be compared to retroactively matched controls. Over 3 months, patients will complete 21 mental health modules and 5 telecoaching sessions. In the following 3 months, they will complete any outstanding telecoaching sessions and modules while still being monitored, even if they finished all modules and sessions in the first 3 months. The 6 months after that will be the follow-up phase. They will still have access to the Living Well app and may continue to use it, and they will complete the same assessment questionnaires as baseline to identify any changes in their overall mental health.

Waitlist Available
Has No Placebo

Cedars-Sinai Medical Center

Scott Irwin, MD

Have you considered Serzone clinical trials?

We made a collection of clinical trials featuring Serzone, we think they might fit your search criteria.
Go to Trials
Image of Mayo Clinic in Florida in Jacksonville, United States.

Virtual Reality for Cancer

18 - 90
All Sexes
Jacksonville, FL

This clinical trial tests the safety, tolerability, and effectiveness of a virtual reality intervention to improve psychological symptom burden for cancer patients undergoing treatment. Virtual reality (VR) is a technology that allows users to experience and interact with three-dimensional, computer-generated environments that simulate the real world or imagined settings. The VR intervention consists of a preloaded with immersive environments designed to engage the senses through simulated sights and sounds. This may include a walk through of a serene forest, exploring vibrant coral reefs, swimming with dolphins, or standing at the base of a majestic waterfall. These environments are created to provide a relaxing and engaging experience. Completing the VR intervention may be a safe and effective way to improve quality of life, reduce anxiety, enhance focus, and promote healthy living for cancer patients undergoing treatment.

Recruiting
Has No Placebo

Mayo Clinic in Florida

Juan C. Cardenas Rosales, MD

Image of Virtual/ No Physical Facility in Palm City, United States.

Akashic Records Sessions for Mental Health

18+
All Sexes
Palm City, FL

The goal of this clinical study is to learn the impact of two Akashic Records sessions on mental health symptoms in adults. We want to see how sessions are linked to stress, anxiety, and depression, and to resilience (ability to bounce back) and feelings of connectedness (to self, community, and humanity). Main questions this study will answer are: After two sessions, what is the impact on stress, anxiety, and depression? After two sessions, what is the impact on resilience and connectedness? How do participants describe their experience of the sessions? After two sessions, what are participants' views of their problems (insight), emotional experiences (impact) and observable behaviors in their daily life? What participants will do: Complete online surveys about their mood at four points: before the first session, before the second session, after the second session, and again 2 months later. Surveys include: DASS-21 (Depression, Anxiety, and Stress Scale) CD-RISC-10 (Connor-Davidson Resilience Scale) WATTS (Connectedness Scale) A short demographic form and satisfaction survey Attend two individual Akashic Records sessions (50-90 minutes each) over private video platform with a licensed clinical social worker (principal investigator) The first 50 participants will also join a one-hour interview with open ended questions with a licensed clinical social worker (co-investigator) about one week after the second session to share their experience in their own words. Who can take part: Adults ages 18 and older who can read and consent in English and who have experienced stress, anxiety, or low mood in the past year. How the research will happen: Sessions are held by secure video call. Participants will also complete private online surveys before, during, and after the sessions. Some participants may be invited to share their experiences in a one-on-one interview. All information is kept private and names are removed before analysis. Risks and benefits: Talking about personal topics may bring up strong emotions. Licensed clinicians conduct sessions, offer support, and provide referrals if needed. Possible benefits include new insights, greater peace or meaning, and improved coping; benefits are not guaranteed. Why this matters: Many people seek spiritual or transpersonal support for emotional concerns. This pilot study will provide early evidence on whether Akashic Records sessions may be a helpful, low-risk option and will guide future research.

Waitlist Available
Has No Placebo

Virtual/ No Physical Facility

Candice S Rasa, LCSW

Image of University of California, Los Angeles in Los Angeles, United States.

Virtual Reality Reward Training for Depression

18+
All Sexes
Los Angeles, CA

The purpose of this study is to compare the effects of enhanced Virtual Reality-Reward Training (eVR-RT) with an active control condition, Virtual Reality-Memory Training (VR-MT), on positive affect and other clinical symptoms. Enhanced VR-Reward Training is a novel intervention aimed at enhancing savoring of positive experiences among individuals with depression and low positive affect through guided imaginal recounting following immersion in positive VR experiences. The current study tests an enhanced version of this training using improved virtual reality technology. Target enrollment is 80 participants with low positive affect, depression, and impaired functioning, who are at least 18 years old, who will be randomly assigned to 7 weeks of either enhanced Virtual Reality-Reward Training (VR-RT) or Virtual Reality-Memory Training (VR-MT). Participants will complete in-person VR sessions, laboratory assessments, self-report questionnaires as part of the study. A subset of 8 participants randomly assigned to VR-RT will complete fMRI scans and EMA surveys. The total length of participation is around 3 months.

Phase 2
Recruiting

University of California, Los Angeles

Have you considered Serzone clinical trials?

We made a collection of clinical trials featuring Serzone, we think they might fit your search criteria.
Go to Trials